等待开盘 06-01 09:30:00 美东时间
+0.020
+0.10%
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
Truist Securities analyst Ki Bin Kim maintains Netstreit (NYSE:NTST) with a Buy and raises the price target from $21 to $22.
05-12 21:33
今日重点评级关注:Piper Sandler:维持MeiraGTx Holdings"超配"评级,目标价从26美元升至30美元;康托·菲茨杰拉德:维持MKS Inc."超配"评级,目标价从300美元升至400美元
04-23 12:35
今日重点评级关注:HC Wainwright & Co.:维持Century Therapeutics"买入"评级,目标价从2美元升至5美元;Oppenheimer:维持Climb Bio"跑赢大市"评级,目标价从10美元升至18美元
04-22 12:41
NetSTREIT Corp (NYSE:NTST) reported upbeat Q1 results, beating analyst estimates. Raised FY2026 FFO guidance, share closed at $20.89 on Monday.
04-21 21:02
NETSTREIT (NTST) declares $0.22/share quarterly dividend, in line with previous. Forward yield 4.21% Payable June 15; for shareholders of record June 1; ex-div June 1. See NTST Dividend Scorecard, Yie...
04-21 20:40
Netstreit (NTST) was trading lower after the retail REIT reported mixed quarterly financial results. Shares were 0.91% down to $20.70 during after-market trading on Monday. Adjusted FFO of $0.34, up 6...
04-21 05:06
NETSTREIT press release (NTST): Q1 FFO of $0.32. Revenue of $57.06M. Completed $239.0 Million of Gross Investment Activity at 7.5% Blended Cash Yield for First Quarter. Increases 2026 AFFO Per Share G...
04-21 04:18
Netstreit (NYSE:NTST) raises FY2026 FFO guidance from $1.35-$1.39 to $1.36-$1.39 vs $1.33 analyst estimate..
04-21 04:06
Netstreit (NYSE:NTST) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.33 by 3.03 percent. This is a 6.25 percent increase over earnings of $0.32 per share from the same
04-21 04:05